DEXCOM INC's ticker is and the CUSIP is 252131AH0. A total of 54 filers reported holding DEXCOM INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,032 | -27.6% | 4,000 | 0.0% | 0.00% | – |
| Q2 2023 | $12,474 | +10.3% | 4,000 | 0.0% | 0.00% | – |
| Q1 2023 | $11,308 | +2.7% | 4,000 | 0.0% | 0.00% | – |
| Q4 2022 | $11,016 | +37.7% | 4,000 | 0.0% | 0.00% | – |
| Q3 2022 | $8,000 | +14.3% | 4,000 | 0.0% | 0.00% | – |
| Q2 2022 | $7,000 | -41.7% | 4,000 | 0.0% | 0.00% | – |
| Q1 2022 | $12,000 | -7.7% | 4,000 | 0.0% | 0.00% | – |
| Q4 2021 | $13,000 | 0.0% | 4,000 | 0.0% | 0.00% | – |
| Q3 2021 | $13,000 | +30.0% | 4,000 | 0.0% | 0.00% | – |
| Q2 2021 | $10,000 | +11.1% | 4,000 | 0.0% | 0.00% | – |
| Q1 2021 | $9,000 | 0.0% | 4,000 | 0.0% | 0.00% | – |
| Q4 2020 | $9,000 | – | 4,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Elequin Capital, LP | 11,771,000 | $26,632,270 | 5.17% |
| Calamos Advisors LLC | 30,006,000 | $67,881,974 | 0.35% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 5,000,000 | $11,302,500 | 0.05% |
| D. E. Shaw & Co., Inc. | 10,000,000 | $23,351,070 | 0.02% |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 23,000,000 | $52,692,310 | 0.02% |
| BNP PARIBAS FINANCIAL MARKETS | 1,035,000 | $2,337,030 | 0.00% |
| LOOMIS SAYLES & CO L P | 9,739 | $909 | 0.00% |
| JPMORGAN CHASE & CO | 7,065,000 | $13,564,800 | 0.00% |
| FMR LLC | 6,019,000 | $13,590,902 | 0.00% |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 200,000 | $451,600 | 0.00% |